[Hereditary spherocytosis in neonates. Review of our caseload]

N Aramburu Arriaga1, M A Fernández Cuesta, M J Martínez González

  • 1Departamento de Pediatría. Hospital de Cruces. Baracaldo. Vizcaya.

Insights

Hereditary spherocytosis in infants under two months does not worsen prognosis. Blood support needs are highest in the first year, with splenectomy based on age and transfusion needs.

Area of Science:

  • Hematology
  • Pediatric Medicine
  • Genetics

Context:

  • Hereditary spherocytosis (HS) is a genetic hemolytic anemia.
  • Early diagnosis in infants is crucial for management.
  • This study reviews HS cases diagnosed in neonates.

Purpose:

  • To review the diagnosis and follow-up of hereditary spherocytosis in infants under two months old.
  • To analyze clinical presentation, management, and outcomes.

Summary:

  • This retrospective study analyzed 18 infants diagnosed with HS before two months of age.
  • Anemia was universal; hyperbilirubinemia was less common but presented earlier.
  • Most cases followed an autosomal dominant inheritance pattern.
  • Blood support and hemolytic crises were most frequent in the first year.
  • Splenectomy was performed in severe/typical forms at a mean age of 8.25 years.

Impact:

  • Neonatal HS diagnosis does not predict a worse long-term prognosis.
  • Understanding early disease patterns guides timely interventions.
  • Management strategies, including splenectomy, are age and transfusion-dependent.
Abstract